Exisulind in combination with celecoxib modulates epidermal growth factor receptor, cyclooxygenase-2, and cyclin D1 against prostate carcinogenesis: in vivo evidence (Q46972216)
Jump to navigation
Jump to search
scientific article published in October 2007
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Exisulind in combination with celecoxib modulates epidermal growth factor receptor, cyclooxygenase-2, and cyclin D1 against prostate carcinogenesis: in vivo evidence |
scientific article published in October 2007 |
Statements
1 reference
Exisulind in combination with celecoxib modulates epidermal growth factor receptor, cyclooxygenase-2, and cyclin D1 against prostate carcinogenesis: in vivo evidence (English)
1 reference
Bhagavathi A Narayanan
1 reference
Bandaru S Reddy
1 reference
Maarten C Bosland
1 reference
Dominick Nargi
1 reference
Lori Horton
1 reference
Carla Randolph
1 reference
Narayanan K Narayanan
1 reference
1 October 2007
1 reference
1 reference
13
1 reference
5965-5973
1 reference
19
1 reference
Identifiers
1 reference
1 reference